Analysis
TKMS Shares Firm Up Ahead of August’s Key Test
TKMS has been doing the kind of quiet, persistent work that usually gets noticed only after the fact: the stock...
BioNTech’s leadership handover arrives just as guidance tightens
BioNTech is entering a stretch where the story is being reshaped on two fronts at once: the numbers and the...
BMW’s Legal Ghosts Are Laid to Rest, But the Operating Picture Keeps Darkening
The settlement of a long-running legal dispute with supplier Aumovio — the former Continental division — closes a chapter BMW...
ServiceNow’s Contradiction Trade: Wall Street Steps Back, Investors Lean In
The market has a peculiar way of ignoring the very signals it claims to respect. When Goldman Sachs quietly removed...
Google’s Antitrust Reprieve and AI Monetization Milestone Converge in Alphabet’s Latest Rally
The market's mood toward Alphabet shifted decisively this week as investors digested a pair of developments that, taken together, reframe...
XPeng’s Two-Front Battle: Global Ambition Meets Home-Market Fatigue
The paradox at the heart of XPeng's current predicament is hard to miss. Here is a company rolling out a...
Vulcan Energy’s Paper Promise vs. Market Reality: A €2.2 Billion Vote of Confidence the Stock Has Yet to Feel
There is a peculiar disconnect playing out at Vulcan Energy. The company has secured what most lithium developers only dream...
Spero Therapeutics Pivots Away From Infectious Disease as Shares Sink to Historic Lows
The market has delivered a brutal verdict on Spero Therapeutics' corporate reinvention. Shares in the biotech group have tumbled roughly...
Arafura Rare Earths: A Fully-Funded Mine, a Falling Share Price, and the September Test That Could Change Both
The disconnect between Arafura Rare Earths' balance sheet and its share price has rarely been starker. On Monday, the stock...
Bayer’s Long Shadow Finally Lifts: Legal Breakthrough and a Defining Week for the DAX’s Comeback Story
The narrative that has defined Bayer for half a decade is finally shifting. For years, the chemicals-to-pharma group was the...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
